Budesolv

  • Budesolv 1
  • Budesolv 2
Product Description

Marinosolv® – The Enabling Technology Behind BudesolvBudesolv is an innovative aqueous budesonide formulation based on Marinosolv® drug delivery platform, which has the potential to dramatically improve the solubility and bioavailability of poorly water-soluble compounds. This leads to faster therapeutic onset and effective treatment at significantly lower doses.

The technology is broadly applicable across a wide range of drug classes, making it a versatile foundation for next-generation formulations.

Read more Show less

Marinomed Biotech AG

  • Country/Region:
    Austria
  • On CPHI since:
    2020
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Budesolv – unique formulation delivers compelling advantagesStrong symptom relief after the first dose

    Patient-friendly low dose, suitable for pediatric use

    Preservative-free formulation for safe, long-term treatment (of chronic conditions)

    Sterile formulation for enhanced safety

  • Selling Points
    Budesolv has successfully completed a Phase III clinical trial.

    We are actively seeking strategic partners for local and regional licensing and commercialization.

    With its innovative formulation and strong clinical data, Budesolv presents a unique opportunity for companies aiming to strengthen their position and establish a market-leading role—in the allergic rhinitis segment.

  • Model
    nasal spray
More specifications Fewer specifications
Sales Markets
Show more Show less

Marinomed Biotech AG

  • Country/Region:
    Austria
  • On CPHI since:
    2020
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Marinomed Biotech AG (2)

  • Tacrosolv – a novel Marinosolv enabled solution

    Product Tacrosolv – a novel Marinosolv enabled solution

    Marinosolv technology significantly extends ocular tissue penetration, enabling a faster onset of efficacy due to high bioavailability of active pharmaceutical ingredients, while enhancing tolerability and safety through a substantial reduction in dosage and minimized systemic exposure.
  • Solv4U

    Product Solv4U

    Marinosolv® enables a strongly increased solubilization and thereby enhanced bioavailability of hydrophobic small molecules and peptides. Consequently, more efficient treatments of a multitude of diseases can be envisaged. Marinosolv® technology facilitates targeted drug delivery with a low systemic off-ta...

Marinomed Biotech AG resources (1)